Showing results (711-720 of 1,286) with videos related to
Sort By:
Pageof 129
Diabetes Care|June 2, 2023
Effects of Tirzepatide Versus Insulin Glargine on Cystatin C-Based Kidney Function: A SURPASS-4 Post Hoc AnalysisHiddo J L Heerspink, Naveed Sattar, Imre Pavo, et al.Diabetes & Metabolic Syndrome|July 16, 2020
BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: Preliminary findings from UK biobankNaveed Sattar, Frederick K Ho, Jason Mr Gill, et al.European Journal of Preventive Cardiology|August 25, 2022
Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity FederationFrancisco Lopez-Jimenez, Wael Almahmeed, Harold Bays, et al.Rheumatology (Oxford, England)|June 7, 2021
Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease-results of the Immune Metabolic Associations in Psoriatic Arthritis studyLyn D Ferguson, Susanne Cathcart, Dominic Rimmer, et al.The Lancet Regional Health. Europe|May 28, 2024
Non-coronary arterial outcomes in people with type 1 diabetes mellitus: a Swedish retrospective cohort studyTarik Avdic, Björn Eliasson, Araz Rawshani, et al.Ebiomedicine|June 23, 2016
High Serum Immunoglobulin G and M Levels Predict Freedom From Adverse Cardiovascular Events in Hypertension: A Nested Case-Control Substudy of the Anglo-Scandinavian Cardiac Outcomes TrialRamzi Y Khamis, Alun D Hughes, Mikhail Caga-Anan, et al.Annals of the Rheumatic Diseases|December 26, 2013
Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled studyIain B McInnes, Liz Thompson, Jon T Giles, et al.Journal of Sports Sciences|July 30, 2020
Does the association between physical capability and mortality differ by deprivation? Findings from the UK Biobank population-based cohort studyJuan Pablo Rey-Lopez, K W Frederick, Hamish M E Foster, et al.JAMA Cardiology|December 10, 2025
Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial: Interleukin-6 Inhibition and Atherosclerotic Event Rate ReductionPaul M Ridker, Florian M M Baeres, Anders Hveplund, et al.Plos One|July 17, 2018
Dietary and physical activity recommendations to prevent type 2 diabetes in South Asian adults: A systematic reviewMirthe Muilwijk, Mary Nicolaou, Samera A Qureshi, et al.Pageof 129